Article: Appointments And Advancements.

Affymax Inc., of Palo Alto, Calif., appointed Robert Naso executive vice president of research and development, Gene Tutwiler executive vice president of new ventures and Mary Cirtin Fermi senior director of commercial development.

AnorMED Inc., of Vancouver, British Columbia, appointed Felix Baker to its board.

Archemix Corp., of Cambridge, Mass., appointed Larry Gold to its scientific advisory board.

Auxeris Therapeutics Inc., of St. Louis, appointed Jonathan McIntyre chief of development technology and operations.

BioAlliance Pharma, of Paris, appointed Richard Keatinge vice president of business development.

BioPartners ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!